It was hypothesized that chemical-and radiation-induced carcinogenesis might require at least two specific chromosomal events that must coincide within a single target cell: (i) The carcinogenic potencies of physical and chemical agents correlate well with their capacity to damage DNA (for a review, see ref. 1). Furthermore, the lack of enzymatic removal of specific lesions (e.g., pyrimidine dimers and oxygen alkylations) from cellular DNA correlates with the increased incidence of carcinogenesis (2, 3). Unrepaired DNA lesions cause two well-known genetic effects in all biological systems in which they can be assayed: mutations and recombinations (or chromosomal rearrangements and aberrations in general). Therefore, apart from possible as yet undefined epigenetic effects, mutagenesis and chromosomal rearrangements should be tested for causal involvement in carcinogenesis. If one or both of these genetic effects constituted major rate-limiting step(s) in carcinogenesis, one would expect to find that some of the human hereditary diseases associated with high risk of spontaneous carcinogenesis might exhibit high spontaneous mutation or chromosomal rearrangement frequencies (or both). Indeed, somatic cells from patients suffering from three major cancer-prone syndromes, Bloom's, Fanconi's anemia, and ataxia telangiectasia, show high levels of spontaneous chromosomal instability (4, 5); their spontaneous mutation rates have not been determined. All tested cells from patients with Bloom's syndrome and Fanconi's anemia show specific patterns of chromatid interchanges (quadriradial chromosomes) consistent with the notion that they represent human hyperrecombination mutants, the former involving predominantly reciprocal mitotic crossovers among homologous chromosomes and the latter involving mostly translocations among nonhomologous chromosomes (4). This latter pattern of chromatid interchanges can be induced in normal human and animal cells treated with carcinogens (refs. 6-8 and this work).
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG-induced mutagenesis, chromosomal aberrations, sister chromatid exchanges, and cell killing in V79 Chinese hamster cells. We show that antipain inhibited MNNG-induced chromosomal exchanges and all other chromosomal aberrations exclusively. This result leads us to postulate that MNNG-induced DNA lesions cause chromosomal aberrations which arise through an antipainsensitive cellular process, that some chromosomal rearrangement is a rate-limiting step in carcinogenesis, and that mutagenesis alone, if required, is not sufficient to accomplish carcinogenesis.
The carcinogenic potencies of physical and chemical agents correlate well with their capacity to damage DNA (for a review, see ref. 1) . Furthermore, the lack of enzymatic removal of specific lesions (e.g., pyrimidine dimers and oxygen alkylations) from cellular DNA correlates with the increased incidence of carcinogenesis (2, 3) . Unrepaired DNA lesions cause two well-known genetic effects in all biological systems in which they can be assayed: mutations and recombinations (or chromosomal rearrangements and aberrations in general). Therefore, apart from possible as yet undefined epigenetic effects, mutagenesis and chromosomal rearrangements should be tested for causal involvement in carcinogenesis. If one or both of these genetic effects constituted major rate-limiting step(s) in carcinogenesis, one would expect to find that some of the human hereditary diseases associated with high risk of spontaneous carcinogenesis might exhibit high spontaneous mutation or chromosomal rearrangement frequencies (or both). Indeed, somatic cells from patients suffering from three major cancer-prone syndromes, Bloom's, Fanconi's anemia, and ataxia telangiectasia, show high levels of spontaneous chromosomal instability (4, 5) ; their spontaneous mutation rates have not been determined. All tested cells from patients with Bloom's syndrome and Fanconi's anemia show specific patterns of chromatid interchanges (quadriradial chromosomes) consistent with the notion that they represent human hyperrecombination mutants, the former involving predominantly reciprocal mitotic crossovers among homologous chromosomes and the latter involving mostly translocations among nonhomologous chromosomes (4). This latter pattern of chromatid interchanges can be induced in normal human and animal cells treated with carcinogens (refs. 6-8 and this work).
This work is an initial attempt to ask the question whether carcinogen-induced mutagenesis or chromosomal rearrangements (or both) are rate-limiting steps in carcinogenesis. We exploit the fact that antipain, a natural protease inhibitor and an anticarcinogenic agent, is also an inhibitor of cellular transformation induced by radiation (9) and chemical carcinogens (10) in rodent cell cultures. (See Fig. 1 for structure.) We tested whether antipain would exhibit any inhibitory effect upon mutagenesis and chromosomal aberrations induced in Chinese hamster V79 cells by a potent mutagenic carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). We found that only MNNG-induced chromosomal aberrations were strongly inhibited by antipain, whereas mutagenesis and sister chromatid exchanges remained unaffected, suggesting that some chromosomal rearrangement(s) might constitute a ratelimiting step in carcinogenesis, whereas mutagenesis, if required, may not be sufficient to accomplish malignant cell transformation.
MATERIALS AND METHODS V79-4 Chinese hamster lung fibroblasts were routinely maintained in Dulbecco's modification of Eagle's minimal essential medium supplemented with 10% (vol/vol) fetal bovine serum, in a humidified incubator at 37°C with a gas phase of 5% CO2 in air. For sister chromatid exchange (SCE) analysis, exponentially growing cells were exposed simultaneously to 30 ,uM BrdUrd and either 0.2 or 0.5 ,ig of MNNG per ml (diluted from 1 mg/ml stock solution in concentrated acetate buffer, pH 5.0) in the presence and absence of the antipromoter antipain (gift from T. Sugimura, National Cancer Research Center, Tokyo, and W. Troll, New York University). Until chromosome fixation, all cultures were kept in the dark. Twenty-six to twentyeight hours after mutagen treatment, Colcemid (0.2 ,uM) was added and the cells were incubated for 2 hr; the mitotic cells were isolated by "mitotic shake off." Metaphase preparations and differential staining were essentially as described by Perry and Wolff (12) . All visible metaphases were scored for aberrations; a smaller random sample was scored for SCEs. MNNG toxicity had previously been determined by survival experiments.
Abbreviations: MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; 6SGua, 6-thioguanine; SCE, sister chromatid exchange.
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H2N-C=NH
Chemical formula of antipain, an inhibitor of papain, trypsin, and cathepsis A and B, isolated from ascomycetes (ref.
11).
The frequency of MNNG-induced forward mutations to 6-thioguanine (6SGua) resistance was quantitated essentially by the method of Myhr and Di Paolo (13) , which involved cell dispersion during an expression period of 200 hr prior to selection in 6SGua. Plates to determine survival (five per treatment) were inoculated with 500 cells per plate. The mutagenesis assay plates (nine per point) were set up in parallel, at a plating density of 4 X 104 cells per plate, and the selective medium containing 6SGua (1 jg/ml) was added. Where necessary, 1 mM antipain (600 ,g/ml) was present during the entire treatment and expression period. RESULTS MNNG concentrations of 0.2 sg/ml and 0.5 Aig/ml caused little toxicity to V79 Chinese hamster cells in culture in the presence of BrdUrd (Table 1 ), yet high frequencies of SCEs (Table 2) and of exchange-type chromosomal aberrations, such as quadriradials (chromatid exchanges) and triradials (see refs. 4 and 14 for classification) were observed ( Fig. 2 and Table 3 ). MNNG at a concentration of 0.5 ,ug/ml was twice as effective as at 0.2 ,ug/ml in inducing chromosomal aberrations (Table 3) , but did not cause any further increase in SCEs (Table 2) . When 1 mM antipain was added together with MNNG, few chromosomal aberrations could be observed (Table 3) . To test whether antipain prevented MNNG-induced cellular and chromosomal damage, we analyzed survival, SCEs, and mutagenesis towards 6SGua resistance. None of these effects appeared to be significantly affected by 1 mM antipain (Tables 1, 2 , and 4). Hence, antipain does not protect cellular DNA against MNNG-induced DNA lesions. Many agents exhibit a cell cycle-dependent effect on chromosomal aberrations. To assess the eventual effects of antipain on the cell cycle of MNNG-treated cells, we monitored the incidence of metaphases with harlequin (dark/light-stained) chromosomes (i.e., cells having completed two rounds of DNA replication). No significant effect of antipain was found and Table 3 ). The left-hand values for SCEs in treatments 1 and 2 are derived from Exp. II; the right-hand values are derived from a separate experiment (V) designed to investigate the effect of antipain alone (see also Table 3 ). The differences between treatments 3-6 are not statistically significant by the F test. SCEs were evenly distributed among all metaphases.
the data presented in Table 3 concern only metaphases with harlequin chromosomes. Furthermore, over the time interval for these experiments, growth in the presence of MNNG was not significantly affected by antipain (Fig. 3) .
Finally, the frequency of MNNG-induced chromosomal aberrations in the presence and absence of antipain was estimated at six different time intervals (0-40 hr). The peak effect was 30 hr after MNNG treatment; antipain inhibition of chromosomal aberrations was observed at all time intervals (Table 5 ). Because the latter experiment was done in the absence of BrdUrd, the phenomenon appears to be independent of BrdUrd labeling.
DISCUSSION
Antipain and leupeptin were originally isolated from ascomycetes as inhibitors of proteases such as papain and trypsin (11) . Both were then shown to inhibit chemically induced mouse skin carcinogenesis (15), whereas antipain alone was shown to reduce the frequency of methylcholanthrene-and x-ray-induced malignant cell transformation in C3H 10T1/2 mouse fibroblasts (9, 10) .
MNNG is a powerful carcinogen and the first chemical shown to transform human cells in culture (16) . Thus, in agreement with our previous hypothesis (17) , one would expect MNNG, as a solitary carcinogen, to induce both recessive chromosomal changes (initiation events) and promotional aberrant mitotic segregation events (e.g., mitotic recombination, nondisjunction, or other chromosomal rearrangements) leading to homozygosity or hemizygosity and the concomitant expression of the malignant phenotype (see also refs. 18 and 19). Indeed, this study showed MNNG to be highly efficient in the Table 2 ). The inhibitory effect of antipain on MNNG-induced chromosomal aberrations (compare treatments 3 and 4 and treatments 5 and 6) is highly significant for both doses of MNNG according to the variance analysis (F values for treatments 3/4 and 5/6 are 30.897 and 34.384, respectively, whereas 6.76 and 6.70 would be sufficient for high significance). * The incidence of MNNG-induced quadriradial chromosomes involving nonhomologs was roughly 10 times more frequent than chromosomes involving homologs (see Fig. 2 ). t These were dicentric, ring, and bridged chromosomes.
induction of both mutagenic and chromosomal aberration events.
Because antipain inhibited MNNG-induced morphological transformation in C3H 1OTl/2 cell culture (unpublished data), it might be expected to influence either MNNG-induced chromosomal aberrations and SCEs (17) or MNNG-induced mutagenesis or both simultaneously. Antipain, however, suppressed virtually all MNNG-induced chromosomal aberrations (Tables 3 and 5 ) in the absence of any significant effect on MNNG-induced SCEs, survival, or MNNG-induced mutagenesis to 6SGua resistance (Tables 2 and 4 ). The possibility that antipain rapidly kills all cells that are to suffer a chromosomal aberration is discouraged by the finding that antipain does not decrease the survival of MNNG-treated cells (certainly not for 0.2 ,gg of MNNG per ml; Table 1) and that the inhibitory effect can be seen in cells that have completed two cell divisions, as judged from the harlequin staining of chromosomes from treated cells grown in the presence of BrdUrd. Furthermore, the suppression of chromosomal aberrations by antipain cannot be accounted for by the effects of antipain on cell growth rate (see Results and Fig. 3 and Table 5 ).
MNNG is a potent inducer of exchange-type aberrations with a few simple chromosome breaks (Tables 3 and 5 ). Among cells treated with essentially nontoxic doses, 0.2 ,ug/ml and 0.5 jug/ml, 5-25% of all metaphases contained either quadriradial or triradial chromosomes (Table 3) . Such quadriradial chromosomes have been interpreted as mitotic exchanges (i.e., nonsister chromatid exchanges between homologs and nonhomologs) (4, (6) (7) (8) (20) (21) (22) and triradials, as incomplete mitotic exchanges (7) . Thus, if these chromosomal configurations are related to mitotic recombination among homologous and nonhomologous chromosomes and if such recombination were responsible for tumor promotion, MNNG would appear to be an efficient promoter in addition to being a potent mutagen ( Table 4) .
The inhibition by antipain of MNNG-induced exchange-type Finally, this discussion may be relevant to the interpretation of the chromosomal effects of human cancer-prone diseases. Bloom's syndrome, Fanconi's anemia, and ataxia telangiectasia are all characterized by high levels of spontaneous chromosomal instability (4, 5) . Because the spectrum of MNNG-induced chromosomal aberrations inhibited by antipain is similar to that observed in Fanconi's anemia-i.e., triradial chromosomes and quadriradial chromosomes, involving nonhomologs predominantly (Table 3 and Fig. 2 ) (4)-it is interesting to speculate that chromosomal aberrations represent a rate-limiting step in carcinogenesis (17) , whereas mutagenesis, if required, may not be sufficient to accomplish carcinogenesis. Chromosomal aberrations could be the basis for both carcinogenic initiation (e.g., deletion mutagenesis) and promotion (e.g., chromosomal rearrangements causing segregation to homozygosity) steps. The qD deletion of one chromosome 13 in cells from hereditary retinoblastoma patients may well represent an inherited initiation event (+/del genotype) which requires a second, somatic event, segregational or mutational, leading to the del/del or mut/del genotypes, respectively (see also ref. 25) .
